We believe our results increase the reliability of the association between IP-10 and progressive NAFLD; however, a longitudinal study is needed to confirm the role IP-10 plays in the development of NAFLD and incident diabetes. The gene discussed is CXCL10; the disease is metabolic dysfunction-associated steatotic liver disease.